JP2024511676A5 - - Google Patents
Info
- Publication number
- JP2024511676A5 JP2024511676A5 JP2023560767A JP2023560767A JP2024511676A5 JP 2024511676 A5 JP2024511676 A5 JP 2024511676A5 JP 2023560767 A JP2023560767 A JP 2023560767A JP 2023560767 A JP2023560767 A JP 2023560767A JP 2024511676 A5 JP2024511676 A5 JP 2024511676A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- anesthetic
- dosage form
- phenylcyclohexyl
- methylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163170211P | 2021-04-02 | 2021-04-02 | |
| US63/170,211 | 2021-04-02 | ||
| PCT/IB2022/053085 WO2022208478A1 (en) | 2021-04-02 | 2022-04-01 | Use of an orexin 2 receptor agonist for post operation recovery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511676A JP2024511676A (ja) | 2024-03-14 |
| JP2024511676A5 true JP2024511676A5 (https=) | 2025-04-15 |
Family
ID=81326367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560767A Pending JP2024511676A (ja) | 2021-04-02 | 2022-04-01 | 術後回復のためのオレキシン２受容体アゴニストの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240165092A1 (https=) |
| EP (1) | EP4313045A1 (https=) |
| JP (1) | JP2024511676A (https=) |
| KR (1) | KR20230165782A (https=) |
| CN (1) | CN117396203A (https=) |
| AU (1) | AU2022252108A1 (https=) |
| BR (1) | BR112023020104A2 (https=) |
| CA (1) | CA3215906A1 (https=) |
| CO (1) | CO2023013001A2 (https=) |
| MX (1) | MX2023011669A (https=) |
| TW (1) | TW202304437A (https=) |
| WO (1) | WO2022208478A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202502342A (zh) * | 2023-06-02 | 2025-01-16 | 日商武田藥品工業股份有限公司 | 食慾素２受體促效劑用於改善睡眠期間之呼吸功能的用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854204A (en) | 1995-03-14 | 1998-12-29 | Praecis Pharmaceuticals, Inc. | Aβ peptides that modulate β-amyloid aggregation |
| JP2001500852A (ja) | 1996-08-27 | 2001-01-23 | プレーシス ファーマスーティカルズ インコーポレイテッド | Ｄ―アミノ酸を含むβ―アミロイドペプチド凝集のモジュレーター |
| PL3411358T3 (pl) * | 2016-02-04 | 2022-02-28 | Takeda Pharmaceutical Company Limited | Podstawiony związek piperydynowy i jego zastosowanie |
| US11034700B2 (en) | 2017-03-08 | 2021-06-15 | Takeda Pharmaceutical Company Limited | Substituted pyrrolidine compound and use thereof |
| WO2018164191A1 (ja) | 2017-03-08 | 2018-09-13 | 武田薬品工業株式会社 | 置換ピロリジン化合物およびその用途 |
| US11319286B2 (en) | 2017-08-03 | 2022-05-03 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and application thereof |
| US20200207734A1 (en) | 2017-08-03 | 2020-07-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| US12077522B2 (en) | 2018-06-29 | 2024-09-03 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and application thereof |
| JP7413261B2 (ja) | 2018-06-29 | 2024-01-15 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| EP3896060B1 (en) | 2018-12-12 | 2023-08-16 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JP7379374B2 (ja) | 2018-12-12 | 2023-11-14 | 武田薬品工業株式会社 | 複素環化合物 |
| SG11202106791XA (en) | 2019-01-31 | 2021-07-29 | Takeda Pharmaceuticals Co | Heterocyclic compound and use thereof |
| US11098029B2 (en) | 2019-02-13 | 2021-08-24 | Merck Sharp & Dohme Corp. | 5-alkyl pyrrolidine orexin receptor agonists |
| WO2020167701A1 (en) | 2019-02-13 | 2020-08-20 | Merck Sharp & Dohme Corp. | Pyrrolidine orexin receptor agonists |
| WO2021026047A1 (en) | 2019-08-08 | 2021-02-11 | Merck Sharp & Dohme Corp. | Heteroaryl pyrrolidine and piperidine orexin receptor agonists |
| CA3154321A1 (en) * | 2019-09-13 | 2021-03-18 | Takeda Pharmaceutical Company Limited | Tak-925 for use in treating narcolepsy |
-
2022
- 2022-04-01 BR BR112023020104A patent/BR112023020104A2/pt unknown
- 2022-04-01 CN CN202280037124.XA patent/CN117396203A/zh active Pending
- 2022-04-01 US US18/553,348 patent/US20240165092A1/en active Pending
- 2022-04-01 CA CA3215906A patent/CA3215906A1/en active Pending
- 2022-04-01 TW TW111112864A patent/TW202304437A/zh unknown
- 2022-04-01 AU AU2022252108A patent/AU2022252108A1/en active Pending
- 2022-04-01 WO PCT/IB2022/053085 patent/WO2022208478A1/en not_active Ceased
- 2022-04-01 EP EP22715747.6A patent/EP4313045A1/en active Pending
- 2022-04-01 KR KR1020237033928A patent/KR20230165782A/ko active Pending
- 2022-04-01 MX MX2023011669A patent/MX2023011669A/es unknown
- 2022-04-01 JP JP2023560767A patent/JP2024511676A/ja active Pending
-
2023
- 2023-09-29 CO CONC2023/0013001A patent/CO2023013001A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yaster et al. | Opioid agonists and antagonists | |
| Bakri et al. | Comparison of dexmedetomidine and dexamethasone for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy | |
| JP2007505139A5 (https=) | ||
| JP2009544619A5 (https=) | ||
| TWI661827B (zh) | 睡眠障礙之治療及預防 | |
| RU2020112530A (ru) | Назальные готовые лекарственные формы и способы их применения | |
| JP2010520185A5 (https=) | ||
| Kim et al. | Comparison of palonosetron with ondansetron in prevention of postoperative nausea and vomiting in patients receiving intravenous patient-controlled analgesia after gynecological laparoscopic surgery | |
| JP2010520183A5 (https=) | ||
| Santos et al. | Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes | |
| JP2011519930A5 (https=) | ||
| JP2024511676A5 (https=) | ||
| JP2010520184A5 (https=) | ||
| US20160213680A1 (en) | Compositions and methods using flumazenil with opioid analgesics for treating pain and/or addiction, and with diversion and/or overdose mitigation | |
| JP2006508040A (ja) | キセノンを含有するアジュバント | |
| CN102068697A (zh) | 含有阿片类镇痛剂和阿片受体拮抗剂的药用组合物 | |
| JP5134973B2 (ja) | 医薬の組み合わせでの処置方法およびこれに適する医薬の組み合わせ | |
| JP2017526719A5 (https=) | ||
| CA2629347A1 (en) | Synergistic combinations of norketamine and opioid analgesics | |
| PT1420789E (pt) | Utilização de substâncias activas com acção agonista do receptor opióide e acção antagonista do receptor opióide como medicamento de combinação para o tratamento do cancro | |
| US20220233492A1 (en) | Method of preventing or treating postoperative pain | |
| Jimenez-Ruiz | Pharmacological treatment for smoking cessation | |
| JP2015533131A (ja) | 咳を治療するためのベータ２−アドレナリン受容体作動薬 | |
| Melanie et al. | Central nervous system toxicity during the induction of general anesthesia after intravenous bolus of lidocaine | |
| Lerche | Opioid Agonists and Antagonists |